 CNBC.com | Novartis drug Afinitor wins EU nod to treat breast cancer CNBC.com The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. American health regulators also backed the drug as a breast cancer treatment[ID ... |
